1887

Abstract

Ganciclovir, foscarnet, vidarabine and ribavirin, which are used to treat viral infections in humans, inhibited the proliferation of a baculovirus ( nucleopolyhedrovirus) in BmN4 cells, a cultured silkworm cell line. These antiviral agents inhibited the proliferation of baculovirus in silkworm body fluid and had therapeutic effects. Using the silkworm infection model, the antiviral activity of Kampo medicines was screened and it was found that cinnamon bark, a component of the traditional Japanese medicine Mao-to, had a therapeutic effect. Based on the therapeutic activity, the antiviral substance was purified. Nuclear magnetic resonance analysis of the purified fraction revealed that the antiviral activity was due to cinnzeylanine, which has previously been isolated from . Cinnzeylanine inhibits the proliferation of herpes simplex virus type 1 in Vero cells. These results suggest that the silkworm–baculovirus infection model is useful for screening antiviral agents that are effective for treating humans infected with DNA viruses.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/vir.0.83208-0
2008-01-01
2024-03-28
Loading full text...

Full text loading...

/deliver/fulltext/jgv/89/1/188.html?itemId=/content/journal/jgv/10.1099/vir.0.83208-0&mimeType=html&fmt=ahah

References

  1. Ansari A., Emery V. C. 1999; The U69 gene of human herpesvirus 6 encodes a protein kinase which can confer ganciclovir sensitivity to baculoviruses. J Virol 73:3284–3291
    [Google Scholar]
  2. Chevaliez S., Brillet R., Lazaro E., Hezode C., Pawlotsky J. M. 2007; Analysis of ribavirin mutagenicity in human hepatitis C virus infection. J Virol 81:7732–7741 [CrossRef]
    [Google Scholar]
  3. Crotty S., Maag D., Arnold J. J., Zhong W., Lau J. Y., Hong Z., Andino R., Cameron C. E. 2000; The broad-spectrum antiviral ribonucleoside ribavirin is an RNA virus mutagen. Nat Med 6:1375–1379 [CrossRef]
    [Google Scholar]
  4. Ejercito P. M., Kieff E. D., Roizman B. 1968; Characterization of herpes simplex virus strains differing in their effects on social behaviour of infected cells. J Gen Virol 2:357–364 [CrossRef]
    [Google Scholar]
  5. EU 1986; Council directive of; 24 November 1986; on the approximation of laws, regulations and administrative provisions of the Member States regarding the protection of animals. used for experimental and other purposes (86/609/EEC) http://ec.europa.eu/food/fs/aw/aw_legislation/scientific/86-609-eec_en.pdf
  6. Godeau F., Saucier C., Kourilsky P. 1992; Replication inhibition by nucleoside analogues of a recombinant Autographa californica multicapsid nuclear polyhedrosis virus harboring the herpes thymidine kinase gene driven by the IE-1(0) promoter: a new way to select recombinant baculoviruses. Nucleic Acids Res 20:6239–6246 [CrossRef]
    [Google Scholar]
  7. Graci J. D., Harki D. A., Korneeva V. S., Edathil J. P., Too K., Franco D., Smidansky E. D., Paul A. V., Peterson B. R. other authors 2007; Lethal mutagenesis of poliovirus mediated by a mutagenic pyrimidine analogue. J Virol 81:11256–11266 [CrossRef]
    [Google Scholar]
  8. Hagiwara K., Matsumoto T. 2000; Nucleotide sequences of genome segments 6 and 7 of Bombyx mori cypovirus 1, encoding the viral structural proteins V4 and V5, respectively. J Gen Virol 81:1143–1147
    [Google Scholar]
  9. Hamamoto H., Sekimizu K. 2005; Evaluation of the therapeutic effects of antibiotics using silkworm as an animal model. Res Adv Antimicrob Agents Chemother 5:1–23
    [Google Scholar]
  10. Hamamoto H., Kurokawa K., Kaito C., Kamura K., Manitra Razanajatovo I., Kusuhara H., Santa T., Sekimizu K. 2004; Quantitative evaluation of the therapeutic effects of antibiotics using silkworms infected with human pathogenic microorganisms. Antimicrob Agents Chemother 48:774–779 [CrossRef]
    [Google Scholar]
  11. Hamamoto H., Kamura K., Razanajatovo I. M., Murakami K., Santa T., Sekimizu K. 2005; Effects of molecular mass and hydrophobicity on transport rates through non-specific pathways of the silkworm larva midgut. Int J Antimicrob Agents 26:38–42 [CrossRef]
    [Google Scholar]
  12. Isogai A., Murakoshi S., Suzuki A., Tamura S. 1977; Chemistry and biological activities of cinnzeylanine and cinnzeylanol, new insecticidal substances from Cinnamomum zeylanicum Nees. Agric Biol Chem 41:1779–1784 [CrossRef]
    [Google Scholar]
  13. Kaito C., Akimitsu N., Watanabe H., Sekimizu K. 2002; Silkworm larvae as an animal model of bacterial infection pathogenic to humans. Microb Pathog 32:183–190 [CrossRef]
    [Google Scholar]
  14. Kaito C., Kurokawa K., Matsumoto Y., Terao Y., Kawabata S., Hamada S., Sekimizu K. 2005; Silkworm pathogenic bacteria infection model for identification of novel virulence genes. Mol Microbiol 56:934–944 [CrossRef]
    [Google Scholar]
  15. Katsuma S., Noguchi Y., Shimada T., Nagata M., Kobayashi M., Maeda S. 1999; Molecular characterization of baculovirus Bombyx mori nucleopolyhedrovirus polyhedron mutants. Arch Virol 144:1275–1285 [CrossRef]
    [Google Scholar]
  16. Kawaguchi Y., Kato K., Tanaka M., Kanamori M., Nishiyama Y., Yamanashi Y. 2003; Conserved protein kinases encoded by herpesviruses and cellular protein kinase cdc2 target the same phosphorylation site in eukaryotic elongation factor 1 δ . J Virol 77:2359–2368 [CrossRef]
    [Google Scholar]
  17. Kool M., Ahrens C. H., Vlak J. M., Rohrmann G. F. 1995; Replication of baculovirus DNA. J Gen Virol 76:2103–2118 [CrossRef]
    [Google Scholar]
  18. Li B., Xia Q., Lu C., Zhou Z., Xiang Z. 2005; Analysis of cytochrome P450 genes in silkworm genome ( Bombyx mori . Sci China C Life Sci 48:414–418 [CrossRef]
    [Google Scholar]
  19. Lowe J. K., Brox L., Henderson J. F. 1977; Consequences of inhibition of guanine nucleotide synthesis by mycophenolic acid and virazole. Cancer Res 37:736–743
    [Google Scholar]
  20. Luque T., Okano K., O'Reilly D. R. 2002; Characterization of a novel silkworm ( Bombyx mori ) phenol UDP-glucosyltransferase. Eur J Biochem 269:819–825 [CrossRef]
    [Google Scholar]
  21. Orlans F. B., Beauchamp T. L., Dresser R., Morton D. B., Gluck J. P. 1998 The Human Use of Animals: Case Studies in Ethical Choice Oxford: Oxford University Press;
    [Google Scholar]
  22. Parker W. B. 2005; Metabolism and antiviral activity of ribavirin. Virus Res 107:165–171 [CrossRef]
    [Google Scholar]
  23. Rohrmann G. F. 1994; Nuclear polyhedrosis viruses. In Encyclopedia of Virology pp 130–137Edited by Webster R. G., Granoff A. London: Academic Press;
    [Google Scholar]
  24. Safronetz D., Petric M., Tellier R., Parvez B., Tipples G. A. 2003; Mapping ganciclovir resistance in the human herpesvirus-6 U69 protein kinase. J Med Virol 71:434–439 [CrossRef]
    [Google Scholar]
  25. Szewczyk B., Hoyos-Carvajal L., Paluszek M., Skrzecz I., Lobo de Souza M. 2006; Baculoviruses – re-emerging biopesticides. Biotechnol Adv 24:143–160 [CrossRef]
    [Google Scholar]
  26. Tanaka M., Kagawa H., Yamanashi Y., Sata T., Kawaguchi Y. 2003; Construction of an excisable bacterial artificial chromosome containing a full-length infectious clone of herpes simplex virus type 1: viruses reconstituted from the clone exhibit wild-type properties in vitro and in vivo. J Virol 77:1382–1391 [CrossRef]
    [Google Scholar]
  27. Tanaka M., Kodaira H., Nishiyama Y., Sata T., Kawaguchi Y. 2004; Construction of recombinant herpes simplex virus type I expressing green fluorescent protein without loss of any viral genes. Microbes Infect 6:485–493 [CrossRef]
    [Google Scholar]
  28. Yagi A. N., Tokubuchi T., Nohara G., Nonaka Nishioka I., Koda A. 1980; The constituents of Cinnamomi Cortex. I. Structures of cincassiol A and its glucoside. Chem Pharm Bull (Tokyo) 28:1432–1436 [CrossRef]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/vir.0.83208-0
Loading
/content/journal/jgv/10.1099/vir.0.83208-0
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error